Measurement of the glycaemic index (GI) of Diben 2 KCAL Drink and Renalive HIGH PROTEIN in healthy subjects

Measurement of the glycaemic index (GI) of Diben 2 KCAL Drink and Renalive HIGH PROTEIN in healthy subjects - GCOS-011-CEN

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00032832

Enrollment

Registered

2023-10-23

Start date

2024-01-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Group 1: Diben 2 KCAL Drink, once p.o., volume containing 25 g or 50 g available carbohydrates (depending on results of nutrient analysis) Group 2: Renalive HIGH PROTEIN, once p.o., volume containing

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Healthy subjects who give informed consent to participate in the study and fulfill the eligibility criteria according to ISO26642 and study protocol

Exclusion criteria

Exclusion criteria: - Aged 60 years; - Pregnant or lactating; - Body mass index (BMI) 30 kg/m2; - Known history of diabetes mellitus or fasting blood glucose value > 6.1 mmol/l or the use of anti-hyperglycaemic drugsor insulin to treat diabetes and related conditions; - Any known food allergy or intolerance; - Medical condition(s) or medication(s) known to affect glucose regulation, tolerance or appetite and/or which influencedigestion and absorption of nutrients (excluding oral contraceptives); - Major medical or surgical event requiring hospitalization within the preceding 3 months; - Use of steroids, protease inhibitors, amphetamines or antipsychotics (all of which have major effects on glucosemetabolism and body fat distribution); - Suspicion of alcohol abuse (defined as an average daily intake of more than 6 units of alcohol per day, e.g. more than 2 pints of beer per day or equivalent amount of alcohol in other beverages) or drug abuse; - Participants who are unable to comply with experimental procedures or do not follow GI testing safety guidelines or are not able to tolerate fasting condition for at least 10 hours

Design outcomes

Primary

Measure	Time frame
Glycaemic index (GI). Blood samples will be taken at -5 min and 0 min before consumption of the product. The baseline value taken as a mean of these two values. The product will be consumed immediately after this within 15 minutes and further bloodsamples will be taken at 15, 30, 45, 60, 90 and 120 minutes after starting to eat/drink.	—

Countries

United Kingdom

Contacts

Public ContactSangeetha Thondre

Oxford Brookes Centre for Nutrition and Health (OxBCNH), Department of Sport, Health Sciences and Social Work, Faculty of Health & Life Sciences, Oxford Brookes University

oxbcnh@brookes.ac.uk+44 (0) 1865 483988

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026